Post Herpetic Neuralgia: Clinical Trials

4 trials for Post Herpetic Neuralgia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Terminated 1

Follow Post Herpetic Neuralgia: new trials by email Literature Review of Post Herpetic Neuralgia trials Research Report on Post Herpetic Neuralgia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia
Pregabalin, placebo - Post Herpetic Neuralgia
Phase 3CompletedPfizer's Upjohn has merged with Mylan to form Viatris Inc.8062011-03-012021-01-28
Eslicarbazepine Acetate as Therapy in Post-Herpetic Neuralgia
Eslicarbazepine acetate (BIA 2-093), Placebo - Post Herpetic Neuralgia
Phase 3TerminatedBial - Portela C S.A.2402010-09-012014-04-07
A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia
Lidocaine 5% medicated plaster - Post Herpetic Neuralgia
Phase 3CompletedGrünenthal GmbH2592003-07-162023-09-13
A Study With Lido-Patch and Placebo Plaster in Patients Suffering From Postherpetic Neuralgia (PHN)
Lidocaine 5% medicated Plaster, Placebo Plaster - Post Herpetic Neuralgia
Phase 3CompletedGrünenthal GmbH2652003-04-292023-09-13

Narrower conditions

Neuralgia, Postherpetic (4)  ·  Herpes Zoster (1)

Broader conditions

Nervous System Diseases (4)  ·  Neuralgia (4)  ·  Neurologic Manifestations (4)  ·  Neuromuscular Diseases (4)  ·  Pain (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Peripheral Nervous System Diseases (4)  ·  Signs and Symptoms (4)  ·  DNA Virus Infections (1)  ·  Herpesviridae Infections (1)  ·  Infections (1)  ·  Varicella Zoster Virus Infection (1)  ·  Virus Diseases (1)

Interventions

Lidocaine (2)  ·  Lidoderm (2)  ·  Pregabalin (1)  ·  eslicarbazepine acetate (1)

Sponsors

Grünenthal GmbH (2)  ·  Bial - Portela C S.A. (1)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1)

Countries

Germany (2)  ·  Bulgaria (1)  ·  Colombia (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Hong Kong (1)  ·  India (1)  ·  Poland (1)  ·  Russia (1)  ·  Serbia (1)  ·  Slovakia (1)  ·  South Africa (1)  ·  Sweden (1)  ·  Taiwan (1)

Results publications

PMID 19366301, PMID 19432499, PMID 22769236, PMID 27753650

NIH funding

2009 (1)